222 related articles for article (PubMed ID: 26648846)
1. Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression.
Jeyachandran A; Mertens B; McKissick EA; Mitchell CS
Front Cell Neurosci; 2015; 9():462. PubMed ID: 26648846
[TBL] [Abstract][Full Text] [Related]
2. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis.
Korhonen P; Pollari E; Kanninen KM; Savchenko E; Lehtonen Š; Wojciechowski S; Pomeshchik Y; Van Den Bosch L; Goldsteins G; Koistinaho J; Malm T
IBRO Rep; 2019 Jun; 6():74-86. PubMed ID: 30705990
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin modulates the immune-inflammatory response of a SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS).
Noh MY; Cho KA; Kim H; Kim SM; Kim SH
Neurosci Lett; 2014 Jun; 574():53-8. PubMed ID: 24820540
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
6. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
7. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Hensley K; Floyd RA; Gordon B; Mou S; Pye QN; Stewart C; West M; Williamson K
J Neurochem; 2002 Jul; 82(2):365-74. PubMed ID: 12124437
[TBL] [Abstract][Full Text] [Related]
8. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
[TBL] [Abstract][Full Text] [Related]
9. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
10. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
11. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
12. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
13. Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis.
Apolloni S; Fabbrizio P; Amadio S; Napoli G; Verdile V; Morello G; Iemmolo R; Aronica E; Cavallaro S; Volonté C
Front Immunol; 2017; 8():1689. PubMed ID: 29250069
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte-Mediated Neuromodulatory Regulation in Preclinical ALS: A Metadata Analysis.
Jordan K; Murphy J; Singh A; Mitchell CS
Front Cell Neurosci; 2018; 12():491. PubMed ID: 30618638
[TBL] [Abstract][Full Text] [Related]
15. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
16. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis.
Elliott JL
Brain Res Mol Brain Res; 2001 Nov; 95(1-2):172-8. PubMed ID: 11687290
[TBL] [Abstract][Full Text] [Related]
17. Anti-Inflammatory Effects of Miyako
Tsuruta K; Shidara T; Miyagishi H; Nango H; Nakatani Y; Suzuki N; Amano T; Suzuki T; Kosuge Y
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762010
[TBL] [Abstract][Full Text] [Related]
18. Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Lerman BJ; Hoffman EP; Sutherland ML; Bouri K; Hsu DK; Liu FT; Rothstein JD; Knoblach SM
Brain Behav; 2012 Sep; 2(5):563-75. PubMed ID: 23139902
[TBL] [Abstract][Full Text] [Related]
19. PGC-1α Silencing Compounds the Perturbation of Mitochondrial Function Caused by Mutant SOD1 in Skeletal Muscle of ALS Mouse Model.
Qi Y; Yin X; Wang S; Jiang H; Wang X; Ren M; Su XP; Lei S; Feng H
Front Aging Neurosci; 2015; 7():204. PubMed ID: 26539112
[TBL] [Abstract][Full Text] [Related]
20. ALS-associated mutation SOD1
Wang H; Yi J; Li X; Xiao Y; Dhakal K; Zhou J
Bone; 2018 Jan; 106():126-138. PubMed ID: 29030231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]